Leveraging multibiomarkers for precision diagnosis of coronary heart disease with phlegm and blood stasis syndrome: a real-world observational study protocol
Open Access
- 27 July 2026
- journal article
- research article
- Published by Wolters Kluwer Health in Guidelines and Standards of Chinese Medicine
- Vol. 4 (3) , 207-212
Abstract
Objective: To assess the diagnostic value of multiple biomarkers, including blood lipid, coagulation, and inflammatory markers, both individually and in combination, for assisting the precision diagnosis of coronary heart disease with phlegm and blood stasis syndrome (CHD-PBSS) in a real-world observational study, thereby providing a scientific basis for future research on the precision diagnosis of CHD-PBSS. Methods: This is a multicenter, real-world observational study designed to recruit 360 patients aged 35 to 70 years with chronic stable CHD from several medical institutions, including Beijing First Hospital of Integrated Chinese and Western Medicine, Yichang Hospital of Traditional Chinese Medicine (TCM), and Huanggang Hospital of TCM. Patients with CHD-PBSS were assigned to the PBSS group ( n = 180), whereas those with CHD but without PBSS (CHD-NPBSS) were assigned to the NPBSS group (n=180). We compared the levels of blood lipid, coagulation, and inflammatory biomarkers between the 2 groups and subsequently evaluated the diagnostic accuracy of these biomarkers, both individually and in combination, for identifying PBSS in patients with CHD. Discussion: The precision diagnosis of PBSS, a critical syndrome in CHD, is crucial for developing effective prevention and management strategies within the framework of TCM. This study aims to identify clinical diagnostic biomarkers of CHD-PBSS through real-world clinical trials, providing a theoretical basis for achieving accurate TCM syndrome diagnosis. However, the observational design has inherent limitations, as it only offers basic demographic information and does not allow for causal inference. In addition, the complexity of TCM syndromes and the subjectivity of clinicians’ judgements may introduce information and selection biases, potentially affecting the accuracy of the results.Keywords
This publication has 15 references indexed in Scilit:
- A review of traditional Chinese medicine diagnosis using machine learning: Inspection, auscultation-olfaction, inquiry, and palpationComputers in Biology and Medicine, 2024
- Proteomics Analysis of Serum Reveals Potential Biomarkers for Heart Failure Patients with Phlegm-Blood Stasis SyndromeJournal of Proteome Research, 2023
- Personalized Intelligent Syndrome Differentiation Guided By TCM Consultation PhilosophyJournal of Healthcare Engineering, 2022
- The interpretation of human body in traditional Chinese medicine and its influence on the characteristics of TCM theoryThe Anatomical Record, 2021
- A randomized controlled trial for gualou danshen granules in the treatment of unstable angina pectoris patients with phlegm-blood stasis syndromeMedicine, 2020
- Epidemiology of cardiovascular disease in China: current features and implicationsNature Reviews Cardiology, 2018
- Deciphering Potential Correlations between New Biomarkers and Pattern Classification in Chinese Medicine by Bioinformatics: Two Examples of Rheumatoid ArthritisChinese Journal of Integrative Medicine, 2018
- The association between blood lipid and phlegm turbidity syndrome of angina pectoris: A systematic review and meta-analysisComplementary Therapies in Medicine, 2014
- Platelet proteomics and its advanced application for research of blood stasis syndrome and activated blood circulation herbs of Chinese medicineScience China Life Sciences, 2013
- Blood stasis syndrome of coronary heart disease: A perspective of modern medicineChinese Journal of Integrative Medicine, 2013